Cargando…

Erythropoiesis‐stimulating agents and incident malignancy in chronic kidney and end‐stage renal disease: A population‐based study

Research investigating incident malignancy risk in erythropoiesis‐stimulating agent (ESA) users with chronic kidney disease (CKD) is lacking. We aimed to compare the incident cancer risk between ESA and non‐ESA users with CKD or end‐stage renal disease (ESRD). In this retrospective cohort study, all...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Yu‐Shan, Li, Ming‐Feng, Lin, Mei‐Chen, Ou, Shih‐Hsiang, Wang, Jen‐Hung, Huang, Chien‐Wei, Chou, Kang‐Ju, Fang, Hua‐Chang, Lee, Po‐Tsang, Hsu, Chih‐Yang, Chen, Jin‐Shuen, Chen, Hsin‐Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468572/ https://www.ncbi.nlm.nih.gov/pubmed/35699124 http://dx.doi.org/10.1111/cts.13353

Ejemplares similares

Secretome of Hypoxic Endothelial Cells Stimulates Bone Marrow-Derived Mesenchymal Stem Cells to Enhance Alternative Activation of Macrophages
por: Chou, Kang-Ju, et al.
Publicado: (2020)

Risk of Renal Function Decline in Patients with Ketamine-Associated Uropathy
por: Ou, Shih-Hsiang, et al.
Publicado: (2020)

Intravitreal Vascular Endothelial Growth Factor Inhibitor Use and Renal Function Decline in Patients with Diabetic Retinopathy
por: Ou, Shih-Hsiang, et al.
Publicado: (2022)

Erythropoiesis Suppression Is Associated with Anthrax Lethal Toxin-Mediated Pathogenic Progression
por: Chang, Hsin-Hou, et al.
Publicado: (2013)

Restricted Use of Erythropoiesis-Stimulating Agent is Safe and Associated with Deferred Dialysis Initiation in Stage 5 Chronic Kidney Disease
por: Pan, Szu-Yu, et al.
Publicado: (2017)

Parathyroidectomy Improves the Consumption of Erythropoiesis-Stimulating Agents in Hemodialysis Patients
por: Lee, Yu-Ting, et al.
Publicado: (2022)

Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and the Risk of Developing Incidental Tuberculosis: A Population-Based Cohort Study
por: Chan, Shan-Ho, et al.
Publicado: (2023)

Potential Role of Vegetarianism on Nutritional and Cardiovascular Status in Taiwanese Dialysis Patients: A Case-Control Study
por: Ou, Shih-Hsiang, et al.
Publicado: (2016)

Effect of anti-diabetic drugs in dialysis patients with diabetes: a nationwide retrospective cohort study
por: Ou, Shih-Hsiang, et al.
Publicado: (2021)

Pharmacological activation of lysophosphatidic acid receptors regulates erythropoiesis
por: Lin, Kuan-Hung, et al.
Publicado: (2016)

Pharmacovigilance in practice: erythropoiesis-stimulating agents
por: Hedenus, Michael, et al.
Publicado: (2014)

Roxadustat treatment for erythropoiesis-stimulating agent-hyporesponsive anemia in maintenance hemodialysis patients
por: Song, Jie, et al.
Publicado: (2023)

End of an era of administering erythropoiesis stimulating agents among Veterans Administration cancer patients with chemotherapy-induced anemia
por: Hoque, Shamia, et al.
Publicado: (2020)

Induced pluripotent stem cell-derived endothelial progenitor cells attenuate ischemic acute kidney injury and cardiac dysfunction
por: Shen, Wen-Ching, et al.
Publicado: (2018)

Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma
por: Chiu, Shih-Hsin, et al.
Publicado: (2014)

Emulsified Nanoparticles Containing Inactivated Influenza Virus and CpG Oligodeoxynucleotides Critically Influences the Host Immune Responses in Mice
por: Huang, Ming-Hsi, et al.
Publicado: (2010)

Erythropoiesis stimulating agents: approaches to modulate activity
por: Sinclair, Angus M
Publicado: (2013)

Altitude Pre-Acclimatization with an Erythropoiesis-Stimulating Agent
por: Heldeweg, Micah L. A., et al.
Publicado: (2023)

Erythropoiesis-stimulating Agent Use among Patients with Lupus Nephritis Approaching End-stage Renal Disease
por: Gómez-Puerta, José A, et al.
Publicado: (2013)

Sedentary Time, Physical Activity Levels and Physical Fitness in Adults with Intellectual Disabilities
por: Hsu, Po-Jen, et al.
Publicado: (2021)

Eighteen years’ experience of traumatic subclavian vascular injury in a tertiary referral trauma center
por: Kou, Hao-Wei, et al.
Publicado: (2019)

Hyponatremia is a surrogate marker of poor outcome in peritoneal dialysis-related peritonitis
por: Tseng, Min-Hua, et al.
Publicado: (2014)

Predictors of In-Hospital Mortality for Road Traffic Accident-Related Severe Traumatic Brain Injury
por: Chen, Chien-Hung, et al.
Publicado: (2021)

Incidence and risk factors for chronic kidney disease in patients with congenital heart disease
por: Fang, Nai-Wen, et al.
Publicado: (2021)

Hemodialysis with end-stage renal disease did not raise the risk of intracranial hemorrhage after a head injury
por: Chen, Hsin-Hung, et al.
Publicado: (2015)

The Current Diagnostic Accuracy on Free Peritoneal Fluid in Computed Tomography to Determinate the Necessity of Surgery in Blunt Bowel and Mesenteric Trauma—Systemic Review and Meta-Analysis
por: Chen, Szu-An, et al.
Publicado: (2021)

Effect of roxadustat on serum metabolome and lipidome in patients with end-stage renal disease and erythropoiesis-stimulating agent resistance
por: Wang, Lichao, et al.
Publicado: (2022)

Use of erythropoiesis-stimulating agents in obese hemodialysis patients
por: Park, Sun-Hee
Publicado: (2018)

Treatment of renal anemia: Erythropoiesis stimulating agents and beyond
por: Biggar, Patrick, et al.
Publicado: (2017)

Tips for erythropoiesis-stimulating agent treatment of renal anemia
por: Tomosugi, Naohisa, et al.
Publicado: (2019)

Erythropoiesis-Stimulating Agent Treatment in Patients With COVID-19
por: Fishbane, Steven, et al.
Publicado: (2020)

Association Between Gout and Injury Risk: A National Retrospective Cohort Study
por: Ou, Shih-Hsiang, et al.
Publicado: (2020)

Subjective and objective assessments of sleep problems in children with attention deficit/hyperactivity disorder and the effects of methylphenidate treatment
por: Chin, Wei-Chih, et al.
Publicado: (2018)

Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis
por: Honda, Hirokazu, et al.
Publicado: (2016)

Sex Differences in the Development of Malignancies among End-Stage Renal Disease Patients: A Nationwide Population-Based Follow-Up Study in Taiwan
por: Chung, Chi-Jung, et al.
Publicado: (2012)

Acetabular Revision Surgery with Tantalum Trabecular Metal Acetabular Cup for Failed Acetabular Cage Reconstruction with Bone Allografts: A Retrospective Study with Mid- to Long-Term Follow-Up
por: Hsu, Chen-Heng, et al.
Publicado: (2022)

Systematic Review of Nutrition Supplements in Chronic Kidney Diseases: A GRADE Approach
por: Lin, Pei-Chin, et al.
Publicado: (2021)

Low cholesterol level associated with severity and outcome of spontaneous intracerebral hemorrhage: Results from Taiwan Stroke Registry
por: Chen, Yu-Wei, et al.
Publicado: (2017)

Changes in Intraocular Pressure after Transepithelial Photorefractive Keratectomy and Femtosecond Laser In Situ Keratomileusis
por: Chou, Chien-Chih, et al.
Publicado: (2021)

Erythropoiesis-stimulating agents: benefits and risks in supportive care of cancer
por: Melosky, B.L.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_c451jt64u0u5osgk0gndcql6do